Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $108,455 - $121,717
-677 Reduced 11.82%
5,049 $891,000
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $20,972 - $23,337
-130 Reduced 2.22%
5,726 $935,000
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $86,113 - $95,237
-512 Reduced 8.04%
5,856 $1.04 Million
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $10,279 - $11,673
-65 Reduced 1.01%
6,368 $1.13 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $8,888 - $9,861
57 Added 0.89%
6,433 $1.1 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $7,752 - $8,614
48 Added 0.76%
6,376 $1.03 Million
Q2 2021

Jul 15, 2021

BUY
$159.48 - $171.07 $31,895 - $34,214
200 Added 3.26%
6,328 $1.04 Million
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $126,588 - $140,986
827 Added 15.6%
6,128 $1.01 Million
Q4 2020

Feb 03, 2021

SELL
$137.11 - $157.38 $84,871 - $97,418
-619 Reduced 10.46%
5,301 $834,000
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $888 - $994
-7 Reduced 0.12%
5,920 $782,000
Q2 2019

Jul 30, 2019

BUY
$131.15 - $144.24 $160,921 - $176,982
1,227 Added 26.11%
5,927 $828,000
Q1 2019

Apr 24, 2019

SELL
$125.72 - $139.79 $345,101 - $383,723
-2,745 Reduced 36.87%
4,700 $657,000
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $710,506 - $855,106
-5,784 Reduced 43.72%
7,445 $961,000
Q3 2018

Oct 29, 2018

SELL
$121.58 - $142.88 $352,703 - $414,494
-2,901 Reduced 17.99%
13,229 $1.83 Million
Q2 2018

Jul 25, 2018

SELL
$119.4 - $131.76 $47,521 - $52,440
-398 Reduced 2.41%
16,130 $1.96 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $216,297 - $256,134
-1,729 Reduced 9.47%
16,528 $2.12 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $2.4 Million - $2.62 Million
18,257
18,257 $2.55 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track West Chester Capital Advisors, Inc Portfolio

Follow West Chester Capital Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Chester Capital Advisors, Inc with notifications on news.